Chemical Compound Review:
Maxair 2-(hydroxymethyl)-6-[1- hydroxy-2-(tert...
Synonyms:
PIRBUTEROL, pyrbuterol, Pirbuterolum, SureCN4819, AG-J-31139, ...
- Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. Colucci, W.S., Alexander, R.W., Williams, G.H., Rude, R.E., Holman, B.L., Konstam, M.A., Wynne, J., Mudge, G.H., Braunwald, E. N. Engl. J. Med. (1981)
- Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure. Rude, R.E., Turi, Z., Brown, E.J., Lorell, B.H., Colucci, W.S., Mudge, G.H., Taylor, C.R., Grossman, W. Circulation (1981)
- Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure. Awan, N.A., Evenson, M.K., Needham, K.E., Evans, T.O., Hermanovich, J., Taylor, C.R., Amsterdam, E., Mason, D.T. Circulation (1981)
- Pirbuterol, a selecttve beta2 adrenergic bronchodilator. Moore, P.F., Constantine, J.W., Barth, W.E. J. Pharmacol. Exp. Ther. (1978)
- Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease. Ashutosh, K., Dev, G., Steele, D. Chest (1995)
- Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure. Weber, K.T., Andrews, V., Janicki, J.S., Likoff, M., Reichek, N. Circulation (1982)
- Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study. Timmis, A.D., Bergman, G., Walker, L., Monaghan, M.J., Jewitt, D.E. International journal of cardiology. (1984)
- Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction. Poppius, H., Lehti, H., Stenius-Aarniala, B. Eur. J. Clin. Pharmacol. (1979)
- Effects of in vivo beta-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol. Kenakin, T.P., Ferris, R.M. J. Cardiovasc. Pharmacol. (1983)
- A comparative trial of pirbuterol and Tedral in patients with reversible airway obstruction. Votteri, B.A., Melcher, L. Annals of allergy. (1979)
- Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber. Solé, D., Villalba, S.R., Sestelo, M.R., Scalabrin, D.M., Soares, F.J., Naspitz, C.K. Revista paulista de medicina. (1993)
- Long-term oral bronchodilator therapy of asthma with pirbuterol. Burki, N.K., Diamond, L. Clin. Pharmacol. Ther. (1978)
- Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease. Richards, D.M., Brogden, R.N. Drugs (1985)
- Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator. Constantine, J.W., McIlhenny, H.M., Moore, P.F. J. Pharmacol. Exp. Ther. (1979)
- Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin. Mittag, T.W., Tormay, A., Messenger, M., Podos, S.M. Invest. Ophthalmol. Vis. Sci. (1985)
- Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure. Canepa-Anson, R., Dawson, J.R., Kuan, P., Poole-Wilson, P.A., Sutton, G.C., Cockrill, B., Reuben, S.R. British journal of clinical pharmacology. (1987)
- Pharmacological actions of various inotropic agents. Scholz, H. Eur. Heart J. (1983)
- Comparison of the Maxair Autohaler to wet nebulizer in patients with acute asthma. Silverman, R., Sellers, J., Greene, S., Flaster, E., Colice, G. Chest (1998)
- A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure. Nelson, G.I., Silke, B., Barker, M.C., Saxton, C.A., Taylor, S.H. Eur. Heart J. (1982)
- Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD. Neilly, J.B., Carter, R., Tweddel, A., Martin, W., Hutton, I., Banham, S.W., Stevenson, R.D. Respiratory medicine. (1989)
- Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler. Völkl, K.P., Kroll, V.M., Wiesemann, H.G., Schneider, B. Arzneimittel-Forschung. (1991)
- Intravenous pirbuterol. Leier, C.V., Nelson, S., Huss, P., Bianchine, J.R., Olukotun, A.Y., Taylor, C.R., Salzburg, D.S. Clin. Pharmacol. Ther. (1982)
- The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy. Biernacki, W., Prince, K., Whyte, K., MacNee, W., Flenley, D.C. Am. Rev. Respir. Dis. (1989)
- Beta 2-adrenergic dilation of conductance coronary arteries involves flow-dependent NO formation in conscious dogs. Hamdad, N., Ming, Z., Parent, R., Lavallée, M. Am. J. Physiol. (1996)